Labcorp Holdings Files 8-K on Financials

Ticker: LH · Form: 8-K · Filed: 2025-07-24T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k, results-of-operations

Related Tickers: LH

TL;DR

Labcorp dropped its 8-K today, check the financials.

AI Summary

Labcorp Holdings Inc. filed an 8-K on July 24, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 358 South Main Street, Burlington, North Carolina.

Why It Matters

This filing provides investors with crucial updates on Labcorp's financial performance and operational results, which can influence investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Labcorp Holdings Inc.'s results of operations and financial condition, and to include financial statements and exhibits.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on July 24, 2025.

What is the official name of the company filing this report?

The official name of the company filing this report is LABCORP HOLDINGS INC.

Where are Labcorp Holdings Inc.'s principal executive offices located?

Labcorp Holdings Inc.'s principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.

What is the SIC code for Labcorp Holdings Inc.?

The Standard Industrial Classification (SIC) code for Labcorp Holdings Inc. is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.

From the Filing

0000920148-25-000075.txt : 20250724 0000920148-25-000075.hdr.sgml : 20250724 20250724065221 ACCESSION NUMBER: 0000920148-25-000075 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250724 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250724 DATE AS OF CHANGE: 20250724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 251144466 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20250724.htm 8-K lh-20250724 0000920148 false 0000920148 2025-07-24 2025-07-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 24, 2025 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-11353 99-2588107 (State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 358 South Main Street   Burlington , North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act: Title of each class Trading Symbol Name of exchange on which registered Common Stock, $0.10 par value LH New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).              Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated July 2 4 , 2025 issued by Labcorp titled “Labcorp Announces 2025 Second Quarter Results” Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant Date: July 24, 2025 By: /s/ SANDRA D. VAN DER VAART     Sandra D. van der Vaart     Executive Vice President, Chief Legal Officer and Corpor

View on Read The Filing